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Intraocular pressure (IOP) elevation is a well-known complication 
after pars plana vitrectomy with or without tamponade. The 
mechanism of increase in IOP can be open angle, closed angle or 
both. Oxidative stress is hypothesized to have a significant role in 
the pathogenesis of post vitrectomy elevated IOP and the presence 
of the lens probably has a protective role. The use of silicone oil 
and intraocular gases as tamponade is related to higher risk of post-
operative elevated IOP. Anti-inflammatory agents, mydriatics, anti-
glaucoma medications especially aqueous suppressants, glaucoma 
surgery and laser procedures might be used for controlling post 
vitrectomy elevated IOP. Glaucoma shunt implantation and 
cyclodestructive procedures are the most important surgeries 
performed for treatment of uncontrolled intraocular pressure after 
vitrectomy.
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Introduction
Elevated intraocular pressure can occur after 
different types of vitreoretinal surgeries 
such as pars plana vitrectomy (PPV) 1,2. The 
pathophysiology can be open-angle, closed-
angle, or a mix mechanism 1, 3-6. 
The vitreous is a very critical part in ocular 
homeostasis 7. The vitreous gel has a higher 
concentration of ascorbate and consumes 
oxygen at a faster rate in comparison to 
liquefied vitreous 7. It has been reported that 
37 % to 95 % of patients undergo cataract 
surgery within 2 years after PPV 8-14.  Increased 
oxidative stress is a contributing factor to the 
pathogenesis of age-related ocular problems 
such as glaucoma 15,16. The results of several 
studies have suggested that vitrectomy 
increases the Oxygen tension within the eye. 
The oxygen pressure is highly elevated in the 
vitreous cavity especially posterior to the lens 
in vitrectomized eyes because of the lack of 
vitreous as a barrier for the oxygen 17-19. This 
elevated oxygen level leads to increased 
oxidative stress on the trabecular meshwork 
especially in aphakia and pseudophakia 
conditions, interfering with the conventional 
outflow facility. The final result of this 
phenomenon is the IOP elevation 20. 
Incidence
The reported incidence of high intraocular 
pressure after vitrectomy is 20 % to 60 % 
3,6,20-24. The first day IOP elevation has been 
reported in 29.5 % of patients after vitrectomy 
but only in 0.5 % of patients after trans 
conjunctival sutureless procedures 25,26. In 
a study by Fang et al., 27 19.5 % of patients 
had elevated IOP after vitrectomy at the 1-year 
follow-up, and in about 68 % of cases the 
elevated IOP occurred within the first month 
after vitrectomy 27. 
Risk factors
Several studies have suggested different 
risk factors for elevated intraocular 
pressure following pars plana vitrectomy 
including combined scleral buckle and 
PPV, endophotocoagulation during surgery, 
vitrectomy combined with lens extraction , 
fibrin formation after surgery, proliferative 
vitreoretinopathy as the underlying cause 
of surgery, family history of open angle 
glaucoma, pre existing glaucoma, diabetes 
mellitus, rubeosis iridis, silicone oil in the 
anterior chamber, high IOP on the first 
post operative day, pre-operative vitreous 
hemorrhage, repeated vitrectomy and 
prominent surgical inflammation 3, 28-31. High 
preoperative IOP, neovascular glaucoma, 
silicone oil emulsification and diabetes 
mellitus are risk factors for poor prognosis of 
glaucoma management post PPV 29. Also post 
PPV elevated IOP occurs sooner in aphakic or 
pseudophakic eyes compared to phakic eyes 
32. An increase in IOP postoperatively is more 
frequent in males and patients undergoing 
surgery for retinal detachment and proliferative 
diabetic retinopathy  25, 33, 34.
Tamponade is a significant risk factor for 
elevated IOP. A study performed by Framme et 
al., 35 among eight hundred and fifty one patients 
comparing air, versus sulfur hexafluoride 
(SF6), versus silicone oil usage as tamponade 
showed that gas tamponade was associated 
with a prolonged elevated IOP, however the 
most significant risk factor for elevated IOP 
was the use of silicone oil. The cumulative 
rates of elevated IOP when using air, balanced 
salt solution, SF6, perfluoropropane (C3F8), 
and silicone oil as the tamponade have been 
reported to be 0 %, 10.8 %, 5.9 %, 19.8 %, and 
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28.4 %, respectively 27. 
Pathophysiology
Secondary open-angle high intraocular 
pressure is the most common mechanism of 
post-vitrectomy elevated IOP, in comparison 
with angle closure mechanism that is 
responsible for only 20 % of cases 3. Open-
angle glaucoma is caused by several factors 
including gas expansion without angle 
closure, inflammation, silicone oil without 
pupillary block, corticosteroid response, and 
blood-mediated mechanisms 4. Angle closure 
mechanisms include pupillary block mediated 
by intraocular gas, silicone oil, fibrin or 
intraocular lens, as well as ciliary body edema 
and iridocorneal apposition 3. Acute post 
operative increase in IOP can be caused by 
replacement of anterior chamber with intra 
ocular tamponade, use of intra operative 
endo-photocoagulation or post operative 
fibrinous inflammatory reaction and late onset 
glaucoma can be due to topical steroid usage 
or pre existing causes such as angle recession 
or neovascular glaucoma 28. 
In normal vitreous, there is a gradient of oxygen 
tension with the highest level being near 
the retinal surface and decreasing gradually 
toward the lens 19. In vitrectomized eyes, 
oxygen tension near the lens rises to 2-3 times 
the preoperative levels 19. In phakic eyes, high 
oxygen level behind the lens causes cataract, 
but in pseudophakic and aphakic eyes, excess 
oxygen tension causes some changes in the 
extracellular matrix in trabecular meshwork 
and resultants in increased IOP 20. 
Prevention
In aphakic and pseudophakic eyes, it is 
preferable to perform at least 150-200 microns 
of iridectomy during surgery to prevent 
pupillary block, but it can close in about 32 % 
of cases; which can be successfully resolved 
using Nd YAG laser 36, 37. It is important to 
know extra-large peripheral iridectomy can 
cause forward migration of the oil 38. The 
usage of transconjunctival (TSV) sutureless 
small gauge ports has a positive impact on 
postoperative IOP. The evidence to support 
immediate use of prophylactic oral or topical 
anti glaucoma medication is currently 
deficient  30.
Management
Most patients with post vitrectomy elevated 
IOP without a previous glaucomatous 
optic neuropathy can tolerate a transient 
postoperative IOP elevation and the majority 
of patients are managed medically 1,9. 
Surgical interventions if needed include 
anterior chamber paracentesis, laser iridotomy, 
laser iridoplasty, laser membranectomy, and 
intracameral injection of recombinant tissue 
plasminogen activator in patients who have a 
fibrin clot in anterior chamber 39,40. Because of 
conjunctival scarring, trabeculectomy does not 
have favorable results. Inoue et al., 31 reported 
that the success rate of trabeculectomy 
with adjunctive mitomycin-C is 55.1 % 
at 1 year, decreasing to 43.1 % at 3 years. 
Glaucoma drainage devices and trans-scleral 
cyclophotocoagulation can be considered in 
eyes with extensive conjunctival scarring. 
Several studies have reported high success 
rates with Molteno and Baerveldt glaucoma 
implants 41,42 .
Elevated intraocular pressure following 
intravitreal gas usage
Intraocular  gases like SF6 and 
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perfluoropropane (C3F8) are frequently used 
as retinal tamponade. These gases are expansile 
with long resorption time, which results in 
more time for choroidal-retinal adhesions. 
However, these properties may also result in 
IOP elevation 43. The incidence of IOP rise 
following intravitreal SF6 and C3F8 injection 
has been estimated to range from 6.1 % to 
67 %, and 18 % to 59 %, respectively 44- 47. 
The higher incidence associated with C3F8 
is thought to be related to its greater maximal 
volume expansion and longer intraocular 
longevity 2.
Changes in the atmospheric pressure can cause 
further expansion of these gases, and an acute 
elevation in IOP 48. Thus the patients are advised 
against a flight travel during the presence 
of intravitreal gas in the early postoperative 
period 48. Johnstone et al., 49 showed that 
trabecular meshwork collapse at low IOP, for 
example due to a decrease in altitude, which 
increases aqueous production in the eye. Upon 
altitude ascent, the gas bubble expands to the 
same size as when it was at hospital discharge, 
but with a larger volume of aqueous, which 
results in IOP rise 49. Furthermore, self-
compensatory mechanisms which include 
choroidal compression, sclera expansion, and 
increased aqueous outflow need time to fully 
accommodate 48,50. Therefore, a rapid rate 
of ascent can overcome the compensatory 
mechanisms and induce high IOP and pain.
Risk factors
There are several variables associated with 
IOP elevation after vitrectomy including 
higher concentrations of the expansile gas, 
use of C3F8, patient age, intraoperative use 
of photocoagulation, concurrent lensectomy 
or placement of circumferential scleral buckle, 
and fibrinous anterior chamber exudates 1. 
Pathophysiology
Secondary glaucoma following intravitreal 
gas injection may be due to both open-angle 
and closed-angle mechanisms. Open-angle 
mechanisms occur when expansion of the 
intraocular gas bubble exceeds the rate of 
outflow of intraocular fluid, or when the 
intraocular gas volume causes posterior 
chamber pressure build-up without angle-
closure 1,3. Secondary closed-angle glaucoma 
results from anterior displacement of the lens-
iris diaphragm causing iridocorneal apposition 
as a result of either pupillary block or non-
pupillary block mechanisms 1,3.
Prevention 
Patient education is an important part of 
management of pars plana vitrectomy with 
intravitreal gas injection to avoid IOP elevation. 
The recommendation for maintaining a prone 
position must be given to prevent anterior 
displacement of the lens-iris diaphragm and 
angle closure. Advice for avoiding flight travel 
is essential for preventing gas expansion and 
IOP elevation, but if a moderate altitude ascent 
is necessary during the post-operative period, 
the physician should prescribe prophylactic 
medication for IOP control, recommend 
gradual ascent and consider modifying the 
amount of gas placed, according to the 
probable traveling 51. Patients should avoid 
rapid altitude changes 51.
Management
Elevations in IOP frequently respond to 
systemic or topical aqueous suppressants or 
oral carbonic anhydrase inhibitors within 24 
to 72 hours 28. When increase in IOP causes a 
compromise in ocular perfusion, aspiration of 
a portion of intravitreal gas may be necessary 
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and when there is pupillary block due to closed 
PI, laser iridotomy may be helpful 28. 
Elevated intraocular pressure following use 
of silicone oil
A known complication of silicone oil (SO) 
use has been reported to be the development 
of secondary elevated intraocular pressure 4. 
The incidence varies widely among studies, 
ranging from 2.2 % to 56 % 29, 52. In a study by 
Matić et al., 53 the mean IOP values in patients 
who received silicone oil during surgery were 
significantly higher compared to the control 
group a month after vitrectomy. In another 
study the onset of IOP elevation was early 
(≤ 1 week) in 61.5 % of the eyes, intermediate 
(1–6 weeks) in 28.7 %, and late (> 6 weeks) in 
9.8 % of the eyes 54. 
Silicon oil can induce early onset post 
operative elevated IOP with several 
mechanisms including overfill with total 
anterior chamber fill resulting in trabecular 
meshwork obstruction, pupillary block with 
silicone oil, denaturation of silicone oil 
into micro droplets with sweeping into the 
trabecular meshwork and inflammation 55-66. 
Possible mechanisms for intermediate- late-
onset elevated IOP after SO injection include 
infiltration of the trabecular meshwork by 
silicone bubbles 67,68, chronic inflammation 60, 
and synechial angle closure 55, 61, 63, rubeosis 
iridis 29,55,59, 65, 69, migration of emulsified and 
non emulsified silicone oil into the anterior 
chamber 29,42, 55, 58, 61, 63, 65, 66, 69-71, and idiopathic 
open-angle glaucoma 55, 63, 65. There may also 
be a direct toxic effect of silicone oil on the 
optic nerve. 
Also emulsification of the silicone oil in the 
micro globules has been associated with a 
rise in the IOP 60, 69,73-75. Emulsified silicone 
oil droplets, which migrate to the trabecular 
meshwork, may cause inflammation of the 
trabecular meshwork, decreased outflow 
facility and secondary open-angle glaucoma 4. 
Prophylaxis
Prophylactic peripheral inferior iridectomy 
or superior iridectomy is performed when 
heavy silicone oil is used as tamponade and is 
helpful for avoiding pupillary block 42. Many 
complications may be prevented or their 
progression arrested when the silicone oil is 
removed a few weeks or months after surgery 
55,76. The intensive use of topical steroid to 
prevent the inflammatory reactions is important 
because the postoperative inflammation can 
lead to occlusion of the iridectomies 76-79.
Management
Treatment of elevated intraocular pressure 
secondary to vitrectomy and silicon oil 
injection depends basically on the mechanism 
of IOP elevation. At first cycloplegic and 
corticosteroids drugs should be started to 
decrease inflammation 4. Then anti glaucoma 
medications especially aqueous production 
inhibitors are used for controlling the 
intraocular pressure 29. Glaucoma drainage 
devices are acceptable surgical options in cases 
that are not controlled with medical therapy 42. 
Because of the possibility of tube obstruction 
with silicone some surgeons insert the device 
plate at the inferotemporal quadrant 80. 
Discussion
Elevated IOP post 20G vitrectomy is well 
documented 3,25,80,81. Emulsified SO causes 
macrophage mediated trabeculitis in the 
conventional outflow pathway and also can 
cause some changes in the collagen network 
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of this area which is why it is better to perform 
silicon oil removal as soon as possible before 
permanent structural changes 82.
According to Fang et al., 27 study the  elevated 
IOP due to silicon oil is more permanent 
compared to gas tamponade 27. A simple 
removal of silicone oil may not to be enough 
for controlling the IOP considering the 
probability of organic changes of trabecular 
meshwork due to contact with emulsified 
silicon oil and it seems preferable to remove 
the oil as soon as possible 28. 
Conclusion
It is important to control intraocular pressure 
post vitrectomy due to possible irreversible 
effects on the optic nerve. The use of silicone oil 
and intraocular gases as tamponade is related 
to higher risk of post-operative elevated IOP 
and causes longer-term IOP elevation. Drugs, 
surgical procedures like shunt implantation 
and cyclodestructive procedures as well as 
laser procedures might be used for controlling 
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